Partnership Opportunities

Partnership Opportunities

Maximize Your Business Prospects in the Rapidly-Expanding RNA-Targeting Small Molecules Space

With the RNA-targeting small molecules field reaching a pivotal point, pharmaceutical companies such as AbbVie, Biogen, andNovartis are racing to become first-in-class. In order to achieve this, they require support in preclinical safety and efficacy studies, screening tools for RNA target discovery, in vivo models, and more. 

Our 2024 industry-focused conference is your premium opportunity to meet and network with 200+ discovery, target validation, preclinical, and translational experts. Make long-lasting connections with potential customers within the RNA-small molecules community and maximize the opportunity to generate revenue for your business 

If you offer relevant services and want to maximize your company’s exposure, contact us today to discuss your bespoke commercial package.  

The field of small molecules targeting RNA is maturing, and biotech companies around the world are racing to become first-in-class.  To achieve this, they need support in assays, screening, sequencing, AI, discovery, preclinical, and more.

Experts need your help with:

Screening Tools & Platforms for RNA Structures 

Artificial Intelligence & Machine Learning

Preclinical CROs for Safety & Efficacy

In Vivo Models for RNA-Targeting Small Molecules 

Why Partner?

Benefit from Market Intelligencein RNA-Targeting Small Molecules Drug Development  

Refresh your client list and discover companies within the RNA-targeting small molecules space, such as AbbVie, Novartis, Ananke Therapeutics, and Expansion Therapeutics to generate new business leads 

Meet & Network with Industry Pioneers from the Likes of Pfizer, Biogen & Arrakis Therapeutics 

Secure invaluable face-to-face time with key decision makers wanting to progress their small molecule drugs from early discovery to preclinical stages through structured networking 

Raise Brand Awareness Within the Community

Increase market share through unique branding formats such as exhibition booths, lead partnership options, or a dedicated presentation to show how your screening techniques can help progress biopharma and academia’s RNA-small molecule drug discovery

Generate Commercial Collaborations  

Make sure your hottest prospects are in the room and part of the discussion by having a wish list of your choice contacted in advance of the event and ensure that you are set up for success in securing significant contacts for desired commercial gain

Get In Touch Now

Alexander Kaczykowski

Senior Business Development Manager

Hanson Wade